The observation that the levels of HMGCL protein were increased after lung cancer cells were treated with IKKβ inhibitors prompted us to examine whether IKKβ promotes the degradation of HMGCL protein by directly phosphorylating it. Here, HMGCL is linked to lung carcinoma.